drugset / Trial / NCT04231708

Effects of Pharmacological Stress and rTMS on Executive Function in Opioid Use Disorder

NCT04231708

Phase 2 Not yet recruiting 20 enrolled Wayne State University
RandomizedCrossoverDouble-blindBasic science

Summary

This preliminary study is designed to evaluate mechanisms by which excitatory dorsolateral prefrontal cortex (dlPFC) repetitive transcranial magnetic stimulation (rTMS) (vs. sham) and pharmacological stress (vs. placebo) alter behavior in non-treatment seeking individuals with opioid use disorder (OUD). Specific Aims are to (1) Evaluate how stress impacts domains of behavior including (1a) executive function and (1b) opioid-seeking behavior; and (2) Determine whether rTMS stimulation attenuates (2a) executive dysfunction, (2b) stress-reactivity, and (2c) opioid-seeking in individuals with OUD not receiving treatment.

Timeline

Start
2026-10
Primary completion
2028-12
Completion
2028-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydrocortisone Other / unclassified 20 mg
Subject Yohimbine Small molecule 54 mg